PTCH1 and Mobius syndrome: The remaining 40% developed SHH-MBs, but significantly extended tumor latency by 146% (160 days), compared with Ptch1+/−p53∆E5-6/ΔE5-6 mice (Figure 1B; Supplementary Figure S1A).